Investor relations

Latest news

IDEXX Elects Joseph L. (Jay) Hooley to Board of Directors

IDEXX to Release 2025 Second Quarter Financial Results

Third Expansion of IDEXX’s Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

IDEXX to Present at Stifel Conference and Announces 2025 Investor Day

IDEXX Announces First Quarter Results

Q1 2025 Earnings Snapshot

IDEXX to Present at Two Upcoming Institutional Investor Conferences

IDEXX Announces Fourth Quarter and Full Year 2024 Results

Q4 2024 Earnings Snapshot

IDEXX Announces Groundbreaking Cancer Dx Panel with Affordable Early Detection Test for Canine Lymphoma

IDEXX Announces Increase in Share Repurchase Program Authorization

IDEXX Announces CFO Transition

IDEXX Announces Third Quarter Results

Q3 2024 Earnings Snapshot

IDEXX to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

IDEXX Announces Second Quarter Results

Q2 2024 Earnings Snapshot

IDEXX Announces Time Change for 2024 Second Quarter Financial Results Conference Call

IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals

IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis

IDEXX to Present at Stifel Conference and Announces 2024 Investor Day

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

IDEXX Launches Vello, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect

IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx, Transforming In-Clinic Workflows

IDEXX Expands Fecal Dx Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years

IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases

IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates

IDEXX Elects Irene Chang Britt to Board of Directors

IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry’s Most Comprehensive Renal Testing Portfolio

Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity

IDEXX Newsroom

Events and presentations

IDEXX Investor Day 2025
Thursday, August 14, 2025, 8:00 am EDT

Second Quarter 2025 Earnings Conference Call
Monday, August 4, 2025, 8:30 am EDT

Stifel Jaws & Paws Conference
Wednesday, May 28, 2025, 10:55 – 11:25 am EDT

First Quarter 2025 Earnings Conference Call
Thursday, May 1, 2025, 8:30 am EDT

Raymond James 46th Annual Institutional Investors Conference
March 3, 2025, 11:35 am – 12:05 pm
View presentation

Fourth Quarter and Full Year 2024 Earnings Conference Call
Monday, February 3, 2025, 8:30 am EST

Third Quarter 2024 Earnings Conference Call
October 31, 2024, 8:30 am EDT

IDEXX Investor Day
August 15, 2024, 8:00 am EDT
View presentation

Second Quarter 2024 Earnings Conference Call
Tuesday, August 6, 2024, 9:00 am EDT

IDEXX Investor & Analyst Session at VMX
Monday, January 15, 2024, 1:00 pm EST
View presentation

Event video
Introducing the IDEXX inVue Dx Cellular Analyzer

View all events and presentations